Jiri Jilek

Title: Jiri Jilek: Innovator in Neuroleptic Compounds

Introduction

Jiri Jilek is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmacology, particularly in the development of neuroleptic compounds. With a total of 2 patents to his name, Jilek's work focuses on creating effective treatments for schizophrenia.

Latest Patents

Jiri Jilek's latest patents include innovative compounds such as N-substituted 2-chloro-7-fluoro-10-piperazino-10,11-dihydrodibenzo (B,F) and 3-fluoro-10-piperazino-8-substituted 10,11-dihydrodibenzo-(b,f) thiepins. These compounds are characterized by their potent antidopaminergic properties and are designed to be non-cataleptic neuroleptics. They are expected to be substantially free of the usual undesired extrapyramidal side effects, making them promising candidates for the treatment of schizophrenia. The preparation techniques for these compounds involve common methods from respective starting compounds, and they can be neutralized with suitable acids to yield addition salts for pharmacological evaluation.

Career Highlights

Jiri Jilek is associated with Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu, a company dedicated to health product manufacturing. His work has led to the development of compounds that exhibit psychotropic activity and low toxicity, contributing to advancements in neuroliptics with significant therapeutic potential.

Collaborations

Jilek has collaborated with notable coworkers such as Miroslav Protiva and Antonin Dlabac. Their combined expertise has furthered the research and development of innovative pharmacological solutions.

Conclusion

Jiri Jilek's contributions to the field of neuroleptics highlight his role as an influential inventor in pharmacology. His innovative compounds are paving the way for more effective treatments for mental health conditions.